Asthma Study

728x90 banner ad_teen_cptrials.jpg

ClinPoint Trials is seeking adults and children over 4 years of age with asthma to participate in a research study.

Why is this study being conducted?

Currently, there are several treatment options that can be used as needed to prevent or relieve asthma symptoms. Although these treatments are commonly used and can be effective, doctors continue to research treatment options for patients with asthma through clinical studies.

In this study, doctors want to learn more about the inhaled study medication (which is a combination of budesonide and albuterol). Separately, these two medications are well-established treatments that have been widely used for asthma. This study medication will be compared to another well-established inhaled medication (albuterol along) to learn about the safety and effectiveness of the study medication in relieving symptoms of asthma in adults and children 4 years of age or older.

What will happen in this study?

You (or your child) will continue to take regular daily asthma medicine to control asthma symptoms and will be given study medication only when asthma worsens to use in addition to your (or your child’s) regular asthma medication.

You or your child will visit our clinic at least 9 times over a minimum 6-month period, with possible additional visits every 3 months until the study is completed.

You will receive all study-related procedures and the study medication at no cost. You will also be reimbursed for your time participating in this study.

Who is eligible to participate in this study?

To be eligible for this study, you or your child must be:

  • At least 4 years of age or older

  • Diagnosed with asthma for at least 1 year

  • Taking medications for asthma

  • Experiencing asthma exacerbation (asthma attacks) in the past 12 months that required additional treatment and/or hospitalization

Other criteria may apply to determine if you are eligible. 

To learn more about this study, or to find out if you (or your child) will qualify, call our office at 972-937-1640 or click here to submit a contact form.

728x90 banner ad_adult_cptrials.jpg

Migraine Headaches

DO YOU SUFFER FROM MIGRAINE HEADACHES?

ClinPoint Trials is seeking individuals who suffer from migraine headaches for a clinical research study. 

Throughout the course of the study, your health will be monitored by the study doctor and the study team. Qualified participants will receive study-related physical exams, lab tests, and investigational study medication at no cost.

Compensation may be provided for time and travel.

Please contact the ClinPoint Trials office at (972) 937-1640 to speak with a Study Coordinator for more information.

Infant Formula for Fussy Babies (Closed)

IS YOUR BABY FUSSY?

ClinPoint Trials is seeking fussy, formula-fed infants for a research study.This is a study for a commercially available infant formula intended for full-term infants 0-12 months of age.

If your infant is formula-fed and fussy, he/she may be eligible to participate. 

To qualify to participate in this study, your infant must be:

  • Healthy

  • Formula-fed

  • Fussy

  • Full-term at birth (not premature)

  • 14-60 days old

  • Not on any medications

For more information or to see if your infant is eligible to participate in this study, please contact ClinPoint Trials at (972) 937-1640

Principal Investigator: Peggy Linguist, M.D.

Lactose Intolerance (Closed)

ClinPoint Trials is seeking individuals with symptoms of lactose intolerance to participate in a clinical research study. 

Giving up dairy can be hard. People with lactose intolerance may have to give up consuming dairy to avoid symptoms such as stomach pain, cramps, bloating, gas movement, release of gas, and diarrhea. Lactose intolerance happens when your body cannot process the sugar in milk (lactose). Lactose intolerance is fairly common - it affects over 40 million people in the United States.

The Liberatus Study aims to find out how well an investigational medication works to improve the symptoms of lactose intolerance (your ability to eat lactose containing foods, like dairy, without discomfort) compared to placebo.

You may qualify for this study if you:

  • Are 18-75 years of age

  • Have a current or recent history of intolerance to milk and other dairy products for at least 1 month

  • Have no other gastrointestinal disorders that could interfere with the study, including Crohn's disease, irritable bowel syndrome, inflammatory bowel disease, ulcerative colitis, Celiac disease or chronic constipation

  • Agree to stop taking all other treatments and products used for lactose intolerance (e.g. Lactaid®, dietary supplements, herbal remedies) throughout the course of the study

  • Agree to abstain from consuming dairy products during certain days of the study and to include dairy products at other times

  • Are willing to complete multiple electronic diary questionnaires at specific time points (sometimes daily, sometimes weekly) during the study, which will capture your daily lactose consumption, any symptoms you may experience, questions about how you are doing, etc.

Other criteria may apply to determine if you are eligible. 

Individuals that qualify to participate will receive compensation for their time, travel, and diary compliance (if applicable). 

For more information or to see if you qualify to participate, please visit the Liberatus Study webisite or call the ClinPoint Trials offices at (972) 937-1640 to speak with a Study Coordinator.

About Lactose Intolerance

Lactose intolerance is a common gastrointestinal condition resulting from the body's inability to process lactose, a sugar found in milk or milk-containing products. For those with lactose intolerance, the small intestine does not break down lactose. Instead, the excess lactose goes undigested into the large intestine. Bacteria in the large intestine ferment the undigested lactose, causing gas production and other gastric symptoms such as abdominal pain, cramping, bloating, gas movement, release of gas, and diarrhea.

Currently there are no prescription treatment options for lactose intolerance, but there are over-the-counter medications and supplements that may help to reduce lactose intolerance symptoms for some people.

About Investigational Medications

"Investigational" means that the medication is still being studied and that the U.S. Food and Drug Administration (FDA) does not yet allow it to be sold in the United States. The FDA allows investigational medications to be used only in research and continually monitor the research and development process. 

Chronic Kidney Disease

ClinPoint Trials is seeking individuals who have been diagnosed with chronic kidney disease for a clinical research study.

You may be eligible to participate in this study if:

  • You are at least 18 years old
  • You have been diagnosed with Chronic Kidney Disease stages 3, 4 or 5

Throughout the course of the study, your health will be closely monitored by the study team and the study doctor. Qualified participants will receive study-related physical exams, lab tests, and investigational study medication or placebo at no cost. Participation is voluntary.

Compensation may be provided for time and travel.

Contact us at (972) 937-1640 for more information.

Post-Herpetic Neuralgia - Pain after Shingles (Closed)

Do you suffer from pain after shingles?

The symptoms of PHN (post-herpetic neuralgia) can be debilitating. The deep burning pain and extreme skin sensitivity can greatly impact the quality of your life. 

ClinPoint Trials is seeking individuals suffering with pain after shingles for a clinical research study.

You may be eligible to participate in this study if:

  • You are at least 18 years old

  • You are suffering with moderate to severe pain after shingles

Throughout the course of the study, your health will be closely monitored by the study team and the study doctor. Qualified participants will receive study-related physical exams, lab tests, and investigational study medication at no cost. Participation is voluntary.

Compensation may be provided for time and travel.

Contact us at (972) 937-1640 for more information.

Osteoarthritis of the Hip or Knee (Closed)

This study is now enrolling participants. More information coming soon. If you would like to see if you qualify to participate in this study, please click the button below to contact us or call our Study Coordinator at (972) 937-1640.

Type 2 Diabetes (Closed)

ClinPoint Trials is seeking adults who have been diagnosed with Type 2 Diabetes for a clinical research study. 

You may be eligible for this study if you are currently taking Metformin. 

Throughout the course of the study, your health will be monitored by the study team and the study doctor. Qualified participants will receive study-related physical exams, lab tests, and investigational study medication or placebo at no cost.

Compensation may be provided for time and travel.

Contact us at (972) 937-1640 for more information.

Migraine Headaches (Closed)

Do you get migraines?

ClinPoint Trials is seeking individuals who get migraine headaches for a clinical research study. 

You may be eligible for this study if you are between the ages of 18 to 75 and have been diagnosed with migraine headaches for at least one year. 

Throughout the course of the study, your health will be monitored by the study team and the study doctor. Qualified participants will receive study-related physical exams, lab tests, and investigational study medication at no cost.

Compensation may be provided for time and travel.

Contact us at (972) 937-1640 for more information.

POLO Study: Pediatric Irritable Bowel Syndrome with Constipation

Is your child suffering from constipation? And pain?

Children who are constipated may complain of abdominal discomfort or pain, have infrequent bowel movements, and when their bowels do move, it might be hard or painful. 

The POLO Clinical Research Study will evaluate the investigational use in children of a study drug that has already been approved by the FDA to treat adults with symptoms of constipation.

To qualify for the POLO Clinical Research Study, your child must meet these criteria that are consistent with Irritable Bowel Syndrome with Constipation (IBS-C):

  • Be between 7 and 17 years old
  • Have 2 or fewer bowel movements a week and may
    • Actively try to stop their bowel movements or
    • Do what doctors call "retentive posturing". They stand straight, on their toes, or may have a red face as they try to stop their bowel movements.
  • Have abdominal pain or discomfort with bowel movements at least for the past 2 months
  • Otherwise, be in relatively good health

Study participants will receive study-related exams, lab tests, and investigational study drug at no charge. Your child's health will be monitored by the Study Nurse and Doctor. 

If your child participates in the POLO Research Study, he/she will visit ClinPoint Trials approximately 6 times in 12 weeks. The study will last approximately 9-12 weeks. Your child will be asked to complete a simple eDiary two times each day. If your child is not able to complete the eDiary, you can complete the diary for your child instead. The study staff will teach the both of you how to use the study diary. 

Don't miss the boat! Call ClinPoint Trials at (972) 937-1640 or visit www.marco-polostudies.com for more information on the POLO Clinical Research Study.

MARCO Study: Pediatric Functional Constipation (Closed)

Is your child suffering from constipation?

Children who are constipated may complain of abdominal discomfort or pain, have infrequent bowel movements, and when their bowels do move, it might be hard or painful. 

The MARCO Clinical Research Study will evaluate the investigational use in children of a study drug that has already been approved by the FDA to treat adults with symptoms of constipation.

To qualify for the MARCO Clinical Research Study, your child must meet these criteria that are consistent with Functional Constipation (FC):

  • Be between 6 and 17 years old

  • Have 2 or fewer bowel movements a week and may

    • Actively try to stop their bowel movements or

    • Do what doctors call "retentive posturing". They stand straight, on their toes, or may have a red face as they try to stop their bowel movements.

  • Have painful or hard bowel movements

  • Otherwise, be in relatively good health

Study participants will receive study-related exams, lab tests, and investigational study drug at no charge. Your child's health will be monitored by the Study Nurse and Doctor. 

If your child participates in the MARCO Research Study, he/she will visit ClinPoint Trials approximately 6 times in 12 weeks. The study will last approximately 9-12 weeks. Your child will be asked to complete a simple eDiary two times each day. If your child is not able to complete the eDiary, you can complete the diary for your child instead. The study staff will teach the both of you how to use the study diary. 

Don't miss the boat! Call ClinPoint Trials at (972) 937-1640 or visit www.marco-polostudies.com for more information on the MARCO Clinical Research Study.